We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pain Control in Renal Colic

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00646061
First Posted: March 28, 2008
Last Update Posted: September 22, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Seoul National University Hospital
  Purpose
Renal colic is very common in emergency department patients. Our aim of this study is which combination of drug is more effective in renal colic.

Condition Intervention Phase
Renal Colic Drug: buscopan Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • pain control

Study Start Date: November 2007
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
morphine, ketorolac, and buscopan
Drug: buscopan
No Intervention: 2
morphine and ketorolac

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adult, clinical suspicion of renal colic

Exclusion Criteria:

  • under 15
  • do not consent
  • contraindication of morphine, ketorolac, or buscopan
  • previously pain controlled
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00646061


Locations
Korea, Republic of
Seoul National University Bundang Hospital
Seongnam-si, Kyeongi-do, Korea, Republic of, 463-707
Sponsors and Collaborators
Seoul National University Hospital
  More Information

Responsible Party: Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00646061     History of Changes
Other Study ID Numbers: B-0705/045-005
First Submitted: March 25, 2008
First Posted: March 28, 2008
Last Update Posted: September 22, 2009
Last Verified: September 2009

Keywords provided by Seoul National University Hospital:
renal colic

Additional relevant MeSH terms:
Colic
Renal Colic
Infant, Newborn, Diseases
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Butylscopolammonium Bromide
Scopolamine Hydrobromide
Parasympatholytics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Muscarinic Antagonists
Cholinergic Antagonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adjuvants, Anesthesia
Mydriatics